基于配体的 CAR 设计增强胶质母细胞瘤中靶向 CD70 的 CAR-T 细胞持久性
Ligand-based CAR design enhances durability of CD70-targeted CAR T cells in glioblastoma.
肿瘤细胞治疗研究
FRONTIER PAPERS
近 5 年肿瘤细胞治疗领域的研究论文。默认按评分排序(权威性 + 新鲜度)。
Ligand-based CAR design enhances durability of CD70-targeted CAR T cells in glioblastoma.
A comparative analysis of CD70-directed CAR-T cells for glioblastoma treatment demonstrates a superior efficacy of the ligand-based construct.
Utilization of universal-targeting mSA2 CAR-T cells for the treatment of glioblastoma.
共 4 条
MEMBER ACCOUNT
登录成功会直接打开下一页。